BioSpace News Archive

New Horizon Biotech Inc. (NHB) has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000 to conduct research and development

VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, announced on March 30 that it had successfully completed its recruiting target of 150 subjects for the Phase-III registration clinical trial in China to evaluate efficacy safety and tolerability of TransCon TM human growth hormone

Partnership combines scalable technology infrastructure with proven clinical services to help meet the growing demand for genetic care

OptraSCAN ®, the leading end-to-end digital pathology solution provider, announced the launch of OS-Ultra 320 the world’s first-ever affordable high-speed digital pathology scanner. The OS-Ultra 320 scans tissues/cells of size 15x15 mm area at 40x magnification in less than 60 seconds and features no-touch continuous loading operation.

Clinical Reference Laboratory (“CRL”), one of the largest privately held clinical testing laboratories in the U.S., announced today that it has partnered with Concentric by Ginkgo, the biosecurity and public health effort at Ginkgo Bioworks (“Ginkgo”)

Completion of $15 million IPO Longwood University Licensing Agreement of chPD1 Two IND Application Filings for chPD1, Isomesothelin, Allogeneic Gamma Delta, CAR-T Therapies GMP Facility Completion, Certification

Vesta, the leader in Community Powered Marketing, announced the launch of their new Applied Consumer Neuroscience suite of tools to seamlessly deliver deeper consumer intelligence from its online community software.

Maypro Industries’ Proprietary Branded Ingredients (PBI) division is proud to announce the publication of new research by Tokiwa Phytochemical (Tokiwa) and the University of Tokyo on a proprietary extract of Kaempferia parviflora (SIRTMAX®), commonly known as black turmeric.

Piramal Pharma Limited’s Contract Development and Manufacturing Organization, Piramal Pharma Solutions, announced that PPL has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals Pvt Ltd. for an upfront consideration of INR 775 crores and earn-outs linked to achievement of milestones.

Apotex Corp is voluntarily recalling three lots of Guanfacine Extended-Release Tablets 2mg to the consumer level due to trace amounts of Quetiapine Fumarate in one lot RX1663.